Akero Therapeutics
Price & Volume
Stats
See more52W Range | $17.86-$58.40 |
Market Cap | $3.9B |
Shares Short | 3M |
Financials
See moreRevenue (12 Mos) | $0 |
Revenue Growth (YoY) | 0% |
Gross Profit (12 Mos) | $0 |
Diluted EPS | -$3.78 |
News
See moreYahoo Finance • 2 days ago
Grabar Law Office is Investigating Claims on Behalf of Long-Term Shareholders of Akero Therapeutics, Inc. (NASDAQ: AKRO); Crocs, Inc. (NASDAQ: CROX); Extreme Networks, Inc. (NASDAQ: EXTR); and Domino’s Pizza Corp. (NASDAQ: DPZ)
Yahoo Finance • 20 days ago
This Stock Just Doubled in 1 Day -- Is It Still a Buy?
Yahoo Finance • 20 days ago
Why Akero Therapeutics (AKRO) Is Among the Best Booming Stocks to Invest in Now?
About
CEO | Dr. Andrew Cheng M.D., Ph.D. |
CFO | Mr. William R. White J.D. |
Address | 601 Gateway Boulevard, South San Francisco, CA, United States, 94080 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 60 |
